26
Participants
Start Date
September 14, 2020
Primary Completion Date
December 12, 2023
Study Completion Date
December 12, 2023
nivolumab
Specified dose on specified days
ipilimumab
Specified dose on specified days
TACE
TACE (Trans-arterial ChemoEmbolization)
Local Institution - 0004, Hong Kong
Local Institution - 0045, Hong Kong
Local Institution - 0136, Buzi
Local Institution - 0029, Tainan City
Local Institution - 0141, Kaohsiung City
Local Institution - 0050, Plainfield
Local Institution - 0078, West Springfield
Local Institution, Vienna
Local Institution - 0020, Brussels
Local Institution, Wollongong
Local Institution - 0048, Wiener Neustadt
Local Institution - 0001, Melbourne
Local Institution - 0013, Sankt Pölten
Local Institution - 0071, Leipzig
Local Institution - 0037, Birtinya
Local Institution - 0010, Adelaide
Local Institution - 0139, Murdoch
Local Institution - 0012, Nice
Local Institution - 0026, Graz
Local Institution - 0131, Sabadell
Local Institution - 0053, Ghent
Local Institution, Monserrato
Local Institution - 0002, Taipei
Local Institution - 0015, Orbassano
Local Institution - 0044, Tapei
Local Institution - 0061, Marseil
Local Institution - 0092, Córdoba
Local Institution - 0132, Caen
Local Institution, Prague
Local Institution - 0102, Santiago de Compostela
Local Institution, Washington D.C.
Local Institution - 0025, Milan
Local Institution - 0064, Dijon
Local Institution - 0101, Madrid
Local Institution - 0183, Madrid
Local Institution - 0084, Madrid
Local Institution - 0018, Madrid
Local Institution, Hanover
Local Institution - 0099, Pamplona
Local Institution - 0082, Englewood
Local Institution - 0070, Vicenza
Local Institution - 0035, Göttingen
Local Institution - 0052, La Tronche
Local Institution - 0005, Louisville
Local Institution - 0059, Louisville
Local Institution - 0030, Taichung
Local Institution - 0057, Taichung
Local Institution - 0135, Daegu
Local Institution, Parma
Local Institution - 0087, Nantes
Local Institution - 0114, Busan
Local Institution - 0046, Reims
Local Institution - 0076, Siena
Local Institution - 0097, Hwasun-Gun
Local Institution - 0014, Lille
Local Institution, Heidelberg
Local Institution - 0093, Paris
Local Institution - 0109, Dallas
Local Institution, Roma
Local Institution - 0021, Clichy
Local Institution - 0189, Coronado
Local Institution - 0094, Villejuif
Local Institution, Messina
Local Institution - 0184, Beijing
Local Institution, Shenyang
Local Institution - 0027, Singapore
Local Institution - 0077, Saint Petersburg
Local Institution - 0009, Saint Petersburg
Local Institution - 0151, Shanghai
Local Institution - 0196, Nanjing
Local Institution - 0089, Singapore
Local Institution, Tianjin
Local Institution - 0011, Singapore
Local Institution, Hangzhou
Local Institution, Hangzhou
Local Institution - 0176, Nanchang
Local Institution, Guangzhou
Local Institution, Guangzhou
Local Institution, Chengdu
Local Institution - 0016, Barnaul
Local Institution - 0209, Xi'an
Local Institution - 0120, Yokohama
Local Institution - 0125, Izunokuni-Shi
Local Institution - 0118, Kanazawa
Local Institution, Federal District
Local Institution - 0039, Québec
Local Institution - 0055, Olomouc
Local Institution - 0108, Chiba
Local Institution - 0122, Matsuyama
Local Institution - 0148, Sapporo
Local Institution - 0113, Yokohama
Local Institution - 0115, Kyoto
Local Institution - 0127, Abeno-ku
Local Institution - 0116, Minato-ku
Local Institution - 0128, Minato-ku
Local Institution - 0121, Musashino-shi
Local Institution - 0119, Hiroshima
Local Institution - 0117, Osaka
Local Institution - 0123, Saitama
Local Institution, Warsaw
Local Institution - 0049, San Juan
Local Institution - 0047, Gyeongsangnam-do
Local Institution - 0161, Seoul
Local Institution - 0186, Seoul
Local Institution - 0160, Seoul
Local Institution - 0164, Seoul
Local Institution - 0023, Alicante
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY